Bone Growth Stimulator Market Size & Share, by Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma); Application (Delayed Union & Non-union Bone Fractures, Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries); End-user (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Home Care) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4601
  • Published Date: Feb 27, 2023
  • Report Format: PDF, PPT

Companies Dominating the Bone Growth Stimulator Market

    • ·DJO, LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Arthrex, Inc.
    • Bioventus LLC
    • Medtronic plc
    • Regen Lab SA
    • Elizur Corporation
    • Ember Therapeutics
    • IGEA S.p.A
    • Ossatec Benelux BV
    • Smith & Nephew PLC

Browse Key Market Insights with Data Illustration:


In The News

  • Bioventus LLC acquired Misonix, Inc., which provides minimally invasive therapeutic ultrasound technologies and regenerative medicine.

  • Arthrex, Inc. has launched the industry's first FDA-cleared SwiveLoc ACL Repair Kit for the repairing of anterior cruciate ligament (ACL) tears.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4601
  • Published Date: Feb 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Globally increasing prevalence of musculoskeletal disorders, worldwide spike in diabetes, and growing prevalence of obesity are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2033.

Inadequate medical settlement associated with bone stimulation products, and stringent approval process of government are estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are DJO, LLC, Arthrex, Inc., Bioventus LLC, Medtronic plc, Regen Lab SA, elizur Corporation, Ember Therapeutics, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, end-user, and by region.

The spinal fusion surgeries segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying